HCPCS Level II · retired code
Q5109 — Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
Q5109 was retired on Dec 31, 2025
CMS ended Q5109 after Dec 31, 2025. Don’t report it for later dates of service. Current codes for the same drug:
Code
CMS HCPCS fileHCPCS codeQ5109
Billing unit10 mg
- Descriptor
- Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Short descriptor
- Injection, ixifi, 10 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2026
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Find the NDC
Med-Code hasn’t mapped Q5109 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
Q5109: common questions
- Is Q5109 a CPT code?
- No. Q5109 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is one billing unit of Q5109?
- One unit of Q5109 is 10 mg, as stated in the code's descriptor. Units to report = dose given ÷ 10 mg. J-code billing units.